Home Archives /C O R R E C T I O N — Boehringer Ingelheim/ /C O R R E C T I O N — Boehringer Ingelheim/April 16, 2026 B In the news release, Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of… Login to continue reading Login Sign up for complimentary access Sign Up Now Close posteditor Articles: 16137 Previous Post CPSC Posts Product Recalls and Product Safety Warnings to its Web Site Next Post FaithTime Launches Prayer Song Generator to Help Believers Turn Personal Prayers Into Songs of Worship